CD40LG and COVID-19: In addition, we found that the responses of S1-113 IgM were higher in mild COVID-19 patients than in severe patients aged <60 years (Figure 1C), and the responses of NSP7 IgM were higher in mild COVID-19 patients than in severe patients aged >80 years (Figure 1F).